Hudkræftklinikken.dk ApS: Financial statements 2025
CVR: 38219960
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. That is a decrease of 7.6% compared with the year before. Equity in the 2025 report amounted to DKK 757,000. The solvency ratio was 42.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,898,097
- Profit/Loss
- DKK -210,331
- Equity
- DKK 757,000
- Total Assets
- DKK 1,791,621
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.9M | -210K | 757K | 3 |
| 2024 | - | 2.1M | 9K | 1.6M | 3 |
| 2023 | - | 1.3M | -211K | 1.6M | 2 |
| 2022 | - | 1.3M | -363K | 1.2M | 2 |
| 2021 | - | 1.8M | 557K | 2.6M | 2 |
Official annual report
How creditworthy is Hudkræftklinikken.dk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 6, 2025, Progressio Invest ApS is registered as an owner of Hudkræftklinikken.dk ApS with an ownership share of 5%.
Hudkræftklinikken.dk ApS has published its annual report for 2024. Gross profit came to DKK 2,055,000, and the net result was DKK 9,266.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.
